[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Lin, 2010 - Google Patents

The effect of manuka honey on enterobacteria

Lin, 2010

View PDF
Document ID
4026626313063839679
Author
Lin S
Publication year

External Links

Snippet

Manuka honey (Leptospermum scoparium) produced in New Zealand has been shown to exhibit substantial antibacterial activity against a broad range of pathogens causing wound infection, and is being used in wound management with excellent results. This activity is due …
Continue reading at researchcommons.waikato.ac.nz (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/47—Hydrolases (3) acting on glycosyl compounds (3.2), e.g. cellulases, lactases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46—Hydrolases (3)
    • A61K38/465—Hydrolases (3) acting on ester bonds (3.1), e.g. lipases, ribonucleases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/02—Measuring or testing processes involving enzymes, nucleic acids or micro-organisms; Compositions therefor; Processes of preparing such compositions involving viable micro-organisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/062—Ascomycota
    • A61K36/064—Saccharomycetales, e.g. baker's yeast

Similar Documents

Publication Publication Date Title
ES2960053T3 (en) Clostridium difficile infection treatment
US12083151B2 (en) Synergistic bacterial compositions and methods of production and use thereof
Gotteland et al. Systematic review: are probiotics useful in controlling gastric colonization by Helicobacter pylori?
Lin Probiotics as functional foods
Angelakis et al. Related actions of probiotics and antibiotics on gut microbiota and weight modification
US8906668B2 (en) Synergistic bacterial compositions and methods of production and use thereof
RU2617952C2 (en) Composition containing n-acetylcysteine in combination with probiotic bacteria able to restore their own stomach barrier effect lost pharma during pharmacological treatment of gastric hyperacidity
US20210177915A1 (en) Probiotics and methods of obtaining same
Yamano et al. Improvement of the human intestinal flora by ingestion of the probiotic strain Lactobacillus johnsoniiLa1
EP1816190B1 (en) New lactic bacteria useful as probiotics
TW201143631A (en) Novel Enterococcus faecium LJS-01 and its use as probiotic
Ammar et al. Campylobacter as a major foodborne pathogen: A review of its characteristics, pathogenesis, antimicrobial resistance and control
RU2439145C2 (en) Strain of microorganism bacillus smithii tbm112 mscl p737 and its application as food or feed additive, or component of probiotic composition, and probiotic composition
EP3209307B1 (en) Probiotic and prebiotic compositions
Mansour et al. Inhibition of Clostridium difficile in mice using a mixture of potential probiotic strains Enterococcus faecalis NM815, E. faecalis NM915, and E. faecium NM1015: novel candidates to control C. difficile infection (CDI)
Ferdouse et al. Probiotic characteristics of Pediococcus pentosaceus and Apilactobacillus kunkeei strains: the lactic acid bacteria isolated from Bangladeshi natural honey
KR101847154B1 (en) Health supplementary food containing lactic acid bacteria
US11666611B2 (en) Defined therapeutic microbiota and methods of use thereof
Lin The effect of manuka honey on enterobacteria
ENTEROBACTERIA THE EFFECT OF MANUKA HONEY ON ENTEROBACTERIA
JP6338206B2 (en) Anti-Helicobacter heilmannii
Kiymaci et al. Probiotic potential and anti-quorum sensing activity of Enterococcus faecalis and Lactobacillus kunkeei isolates from Apis mellifera
Najarian Impact of bioactive molecules secreted by Lactobacillus acidophilus La-5 on Clostridium difficile virulence factors
US11491192B2 (en) Treatment and prevention of pathogenic bacterial overgrowth using butyrate-producing bacteria
AL-Maaqar Evaluation of the antibacterial activity of local honey against bacteria causing diarrhea